This contribution deals with flexographic printing of nanoparticulate tin-doped indium oxide (ITO) inks for the manufacture of fine lines on PET foils and glass substrates. The development and optimization of ITO inks, based on solutions of water and ethanol, for the flexographic printing process is presented. The influence of the solvent composition, of the particle content, and of the molar mass of the binder polyvinylpyrrolidone on the printing result is shown. ITO lines with a minimum line width of around 120 mu m were printed using a printing plate with a feature size of 50 mu m; the ITO lines exhibited a thickness of around 1 mu m. Laser post-treatment was used to consolidate the top layer of the nanoparticulate ITO structures resulting in improved electrical properties; low sheet resistance values of around 300 Omega/a- were achieved
This manuscript presents the conceptional design of indium tin oxide inkjet inks for the manufacture of electron devices. For this purpose, the process window of the printer used is identified and the inks are conceived to meet the requirements. The nano-particles are effectively stabilized in different dispersion media. The rheological, the wetting and the drying behavior of the inks are adapted to the inkjet process and the substrates to be coated. To assemble a field effect transistor (FET), the most suitable ink is chosen and source and drain contacts are printed. In the device, a nano-particulate ZnO layer acts as semiconducting layer and the gate electrode as well as the dielectric layer is formed by a thermally oxidized silicon wafer. The electron device assembled shows the typical FET characteristic proving its functionality
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.